Incheon, South Korea
Samsung Biologics is constructing a 1.3 million-sf pharmaceutical production facility in the Songo International Business District in Incheon, South Korea. Accommodating twelve 15-liter bioreactors, the five-story facility will be the world’s largest biologics manufacturing plant when it opens in 2018. Ground was broken on the project in November of 2015.
Source
